The majority of large health systems and oncology provider groups use clinical pathways in their efforts to standardize cancer treatment, improve patient outcomes, and control costs. According to a recent survey, 70% of healthcare decision-makers use clinical pathways at their organization,¹ and pathway adherence rates of ~80% are reported by one of our panelists.
In this 4-episode video series, Dr Evan Slater and Dr Sophia Humphreys share their perspectives on implementing clinical pathways and measuring the impact.
Episode 2 Measuring Outcomes
Adherence, tolerability, time on treatment, and overall survival are some of the metrics evaluated to measure the impact of clinical pathways.



